摘要 |
The invention is based upon the newly recognized ability of beta chemokines to inhibit cell apoptosis. In particular, apoptosis of T cells is described. The known beta chemokines I-309 and TCA-3 are examples of the beta chemokines which inhibit apoptosis. One aspect of the invention is the use of these molecules to inhibit apoptosis. A second aspect of the invention is the use of beta chemokine inhibitors or antagonists to provoke apoptosis. |